abstract |
The present invention relates to novel substituted thioimidazolidinone compounds and the treatment of diseases and disorders associated with androgen receptors such as prostate cancer, benign prostatic hypertrophy, male hair loss, muscle weakness, acne, and hirsutism. And a pharmaceutical composition comprising the compound. |